Recently, Minnesotans have been receiving unsolicited, unrequested at-home colon cancer screening kits from health insurers, without a doctor's input. If you received one in the mail, you might ...

Guardant’s test analyzes circulating tumor DNA that is then used to identify patients with BRAF V600E-mutant metastatic colorectal cancer who may benefit from treatment with the Braftovi combo therapy ...

(WSVN) - It’s called the “silent surge” — men in their 30s being diagnosed with colon cancer. 7Investigates why their symptoms are often misdiagnosed. Here’s 7’s Courtney Allen. Thirty-four-year-old ...

Most offensive line rotations don't work out well. It's a position where continuity matters. But the Detroit Lions had success shuffling offensive guards in last week's win over the Dallas Cowboys, ...

Treatment with a GLP-1 receptor agonist (RA) may offer a survival advantage in patients with colon cancer and obesity. In a real-world analysis of nearly 7000 patients with colon cancer, those taking ...

Health insurance companies send all kinds of things in the mail: brochures about benefits, branded items such as coasters and duffel bags, and reminders to get certain health tests done. Some have ...

Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading cancer killer for ...

Editor’s note: This story was updated to clarify recommendations for colorectal cancer screening. As a gastroenterologist, the most meaningful part of my job is preventing colorectal cancer by ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...

At a conference earlier this summer, a research team from Inova Schar Cancer Institute in Virginia presented new data on colon cancer in runners. Out of 100 marathoners and ultramarathoners between ...

Findings compared with three opt-in screening strategies among average-risk adults aged 45 to 49 years. HealthDay News — Mailing a stool-based test directly to people’s homes is the most effective ...